Clinical Trial Update: Da Vinci Transoral Robotic-assisted Surgery of Pituitary Gland [NA]

View source ↗

Summary

Clinical trial update for Da Vinci transoral robotic-assisted surgery targeting pituitary neoplasms; study is terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pituitary Neoplasms

Drugs mentioned

• Da Vinci transoral robotic-assisted surgery

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: Pituitary Neoplasms | NA | Status: TERMINATED | Results posted: 2021-03-29